Stock News

EPS for Repligen (RGEN) Expected At $0.12; Last Week Investment Technology Group, Inc. (ITG) Analysts

Among 5 analysts covering Investment Technolgy Group Inc (NYSE:ITG), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. Investment Technolgy Group Inc had 8 analyst reports since September 9, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Tuesday, May 30 by Jefferies. The firm earned “Neutral” rating on Thursday, April 7 by JP Morgan. The stock of Investment Technology Group, Inc. (NYSE:ITG) earned “Hold” rating by Sandler O’Neill on Tuesday, January 9. The firm has “Overweight” rating given on Wednesday, January 20 by JP Morgan. Credit Suisse maintained the stock with “Outperform” rating in Tuesday, March 29 report. See Investment Technology Group, Inc. (NYSE:ITG) latest ratings:

09/01/2018 Broker: Sandler O’Neill Rating: Hold New Target: $21.0 Maintain

Analysts expect Repligen Corporation (NASDAQ:RGEN) to report $0.12 EPS on February, 28.They anticipate $0.04 EPS change or 50.00% from last quarter’s $0.08 EPS. RGEN’s profit would be $5.23M giving it 68.23 P/E if the $0.12 EPS is correct. After having $0.15 EPS previously, Repligen Corporation’s analysts see -20.00% EPS growth. The stock decreased 0.33% or $0.11 during the last trading session, reaching $32.75. About 154,769 shares traded. Repligen Corporation (NASDAQ:RGEN) has risen 59.96% since February 17, 2017 and is uptrending. It has outperformed by 43.26% the S&P500.

Investors sentiment increased to 2.5 in Q3 2017. Its up 1.65, from 0.85 in 2017Q2. It is positive, as 7 investors sold Investment Technology Group, Inc. shares while 23 reduced holdings. 21 funds opened positions while 54 raised stakes. 28.15 million shares or 1.67% less from 28.62 million shares in 2017Q2 were reported. Cramer Rosenthal Mcglynn Limited Liability reported 0.28% in Investment Technology Group, Inc. (NYSE:ITG). Voya Inv has invested 0% of its portfolio in Investment Technology Group, Inc. (NYSE:ITG). Gsa Capital Partners Llp accumulated 30,187 shares. The New York-based Renaissance Ltd Liability Company has invested 0.01% in Investment Technology Group, Inc. (NYSE:ITG). Penn Capital holds 0.21% of its portfolio in Investment Technology Group, Inc. (NYSE:ITG) for 130,805 shares. Loomis Sayles & Lp accumulated 590 shares. Deutsche National Bank & Trust Ag reported 0% of its portfolio in Investment Technology Group, Inc. (NYSE:ITG). Jacobs Levy Equity Inc has invested 0.04% of its portfolio in Investment Technology Group, Inc. (NYSE:ITG). Blackrock invested in 3.52M shares. Citigroup accumulated 21,739 shares or 0% of the stock. National Bank & Trust Of Montreal Can accumulated 145 shares. Great West Life Assurance Can holds 46,262 shares. Bank Of America De owns 329,030 shares for 0% of their portfolio. Panagora Asset holds 0% or 18,751 shares. State Common Retirement Fund accumulated 34,900 shares.

The stock increased 3.28% or $0.65 during the last trading session, reaching $20.44. About 277,146 shares traded or 1.58% up from the average. Investment Technology Group, Inc. (NYSE:ITG) has risen 12.80% since February 17, 2017 and is uptrending. It has underperformed by 3.90% the S&P500.

Investment Technology Group, Inc. operates as an independent broker and financial technology firm in the United States, Canada, Europe, and the Asia Pacific. The company has market cap of $666.36 million. The firm offers various solutions for asset managers and broker-dealers in the areas of execution services, workflow technology, and analytics that provide trade execution services and solutions for portfolio management, as well as investment research, pre-trade analytics, and post-trade analytics and processing. It currently has negative earnings. The firm offers ITG Algorithms and ITG Smart Router that offers portfolio managers and traders to trade orders; POSIT for continuous and scheduled crossing of non-displayed equity orders and price improvement opportunities; ITG Derivatives for electronic listed futures and options trading; ITG Commission Manager, a Web commission management portal; and securities lending services.

Since December 14, 2017, it had 0 insider buys, and 2 insider sales for $772,280 activity. Another trade for 8,970 shares valued at $322,445 was sold by Hunt Anthony. 12,729 shares were sold by Benjamin Howard, worth $449,835.

Investors sentiment decreased to 1.31 in 2017 Q3. Its down 0.75, from 2.06 in 2017Q2. It fall, as 26 investors sold Repligen Corporation shares while 48 reduced holdings. 29 funds opened positions while 68 raised stakes. 34.48 million shares or 3.95% more from 33.17 million shares in 2017Q2 were reported. Florida-based State Board Of Administration Of Florida Retirement System has invested 0% in Repligen Corporation (NASDAQ:RGEN). Goldman Sachs Gp accumulated 0% or 236,374 shares. Perceptive Limited Liability Com reported 87,400 shares. 1.35M are owned by State Street Corporation. Nicholas Investment Ptnrs L P has invested 0.21% in Repligen Corporation (NASDAQ:RGEN). 474,201 are held by Fincl Bank Of Ny Mellon Corp. Fred Alger Mgmt reported 36,000 shares. Us National Bank De reported 0% of its portfolio in Repligen Corporation (NASDAQ:RGEN). Omers Administration has 12,500 shares. Proshare Advisors Ltd Liability Corporation holds 0.01% of its portfolio in Repligen Corporation (NASDAQ:RGEN) for 24,350 shares. Nbw Cap Limited Liability Corporation owns 43,816 shares. California-based Rice Hall James Assoc Ltd has invested 0.11% in Repligen Corporation (NASDAQ:RGEN). Lord Abbett & Communication Ltd owns 0.09% invested in Repligen Corporation (NASDAQ:RGEN) for 841,807 shares. Clarivest Asset Ltd Company invested in 37,717 shares. Bb&T Corp reported 7,875 shares.

Among 8 analysts covering Repligen (NASDAQ:RGEN), 7 have Buy rating, 0 Sell and 1 Hold. Therefore 88% are positive. Repligen had 13 analyst reports since November 6, 2015 according to SRatingsIntel. The rating was upgraded by Piper Jaffray to “Overweight” on Monday, February 13. The rating was initiated by William Blair on Friday, July 21 with “Buy”. The stock of Repligen Corporation (NASDAQ:RGEN) earned “Hold” rating by Jefferies on Thursday, August 3. The firm has “Hold” rating by Jefferies given on Tuesday, June 27. The rating was maintained by Jefferies on Tuesday, September 12 with “Hold”. The rating was maintained by Jefferies with “Hold” on Wednesday, October 18. The rating was initiated by Citigroup with “Buy” on Friday, December 8. The stock of Repligen Corporation (NASDAQ:RGEN) earned “Hold” rating by Jefferies on Thursday, June 8. The company was downgraded on Friday, November 6 by Jefferies. The stock of Repligen Corporation (NASDAQ:RGEN) has “Buy” rating given on Monday, February 22 by Craig Hallum.

Repligen Corporation, a bioprocessing company, focuses on the development, production, and commercialization of products used in the production of antibody therapeutics, recombinant proteins, and vaccines worldwide. The company has market cap of $1.43 billion. It makes various forms of Protein A, a critical component used to purify antibody drugs. It has a 57.46 P/E ratio. The firm also supplies alternating tangential flow system filtration devices and protein cell culture supplements that are used in clinical and commercial stage manufacturing to enhance biologic drug yields.

Leave a Reply

Your email address will not be published. Required fields are marked *